Vanda Pharmaceuticals Inc
VNDA
NASDAQ
Biotechnology
$5.22
USD
+0.19 (+3.78%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $304.35M
Volume 964.6K
Price Target
$20.00 – $20.00
USD
The 1 analysts offering 1-year price forecasts have a max estimate of $20.00 and a min estimate of $20.00.
Past 2Y
1Y Forecast
Price Targets
Average Target
$20.00
+$0.5 vs prior
Implied Upside
+283.1%
+9.6% vs prior
Analyst Covering
1
-1 vs prior period
Consensus
Buy
Unchanged vs prior
Signal Quality
Consensus Freshness
33%
Many ratings are older - consensus may be less current
Analyst Agreement
High
Targets are closely clustered - analysts agree more than usual
Mean vs Median
$0 Gap
Median and average are closely aligned - few outliers skewing the consensus
Analyst Consensus
Strong Sell
Hold
Strong Buy
Buy
1 Buy
0 Hold
0 Sell
Rating Breakdown
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
1 analysts · last 3 months
Covering Analysts
Unlock each analyst's profile, success rate + price targets
Free shows the consensus and each analyst's current rating.
| Analyst | Firm | Rating | Action | Date | Success Rate | Price Target | Implied Upside |
|---|---|---|---|---|---|---|---|
Raghuram Selvaraju | HC Wainwright & Co. | Buy | Maintained | 5 days ago | Plus | Plus | Plus |
Frequently Asked Questions
Similar Stocks
TLSI
TriSalus Life Sciences Inc
$5.27
▼ -6.4%
SION
Sionna Therapeutics Inc
$6.46
▼ -1.2%
AVXL
Anavex Life Sciences Corp
$3.22
▼ -1.5%
FATE
Fate Therapeutics Inc
$2.57
▲ +2.0%
IRD
Opus Genetics Inc
$3.61
▼ -3.0%
ANIK
Anika Therapeutics Inc
$21.50
▲ +1.6%
CAMP
CAMP4 Therapeutics Corp
$5.44
▲ +20.9%
IMRX
Immuneering Corp
$5.06
▼ -2.7%